// App-Quantinova.ai

P1705 : PATIENT-REPORTED OUTCOMES IN MYELOPROLIFERATIVE NEOPLASMS IN CLINICAL TRIALS: A SYSTEMATIC REVIEW

Researchers

Presenter

  • Esther Natalie Oliva

Principal Investigators

  • Sam Salek

  • Edward Laane

  • Marike Andreas

  • Nicole Skoetz

  • Tatyana Ionova

Medical Centers

  • Department of Hematology and Oncology,University of Tartu,Tartu,Estland

  • Department I of Internal Medicine, Evidence-based Oncology,University Hospital of Cologne,Cologne,Deutschland

  • Department of Hematology and Oncology,University of Tartu,Tartu,Estland

  • St. Petersburg State University Hospital,Saint-Petersburg,Russie, Fédération De

  • Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy

  • St. Petersburg State University Hospital,Saint-Petersburg,Russie, Fédération De

  • Department I of Internal Medicine, Evidence-based Oncology,University Hospital of Cologne,Cologne,Deutschland

  • Department of Hematology and Oncology,...

  • Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy

  • Department I of Internal Medicine, Evidence-based Oncology,University Hospi

  • School of Life & Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom

  • Department I of Internal Medicine, Evidence-based Oncology,University Hospital of Cologne,Cologne,Deutschland

  • Department of Hematology and Oncology,University of Tartu,Tartu,Estland

  • St. Petersburg State University Hospital,Saint-Petersburg,Russie, Fédération De

  • St. Petersburg State University Hospital,Saint-

  • Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy

  • School of Life & Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom

  • St. Petersburg State University Hospital,Saint-Petersburg,Russie, Fédération De

  • School of Life and Medical Sciences, University of Hertfordshire,Hatfield,Vereinigtes Königreich

  • Department of Hematology and Oncology,University of Tartu,Tartu,Estland

  • School of Life and Medical Sciences, University of Hertfordshire,Hatfield,Royaume-uni

  • Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy

  • Grand

  • School of Life and Medical Sciences, Unive

Locations

  • Italy

  • United Kingdom

  • Estonia

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A